Skip to main content
Formerly Market Access Monitor

MTRC Access Intelligence

Structured MedTech Market Access Intelligence for Reimbursement, HTA, Payer, and Access Changes

MTRC Access Intelligence helps MedTech, IVD, and digital health companies track relevant market access developments early, understand their implications, and use them for launch planning, portfolio strategy, evidence generation, and internal decision-making

Why Access Intelligence Matters

European market access is changing continuously. Procedure codes are updated, DRG systems evolve, add-on payment routes open or close, payer decisions are published, HTAs are initiated, innovation funding schemes change, and clinical guidelines are revised.

For market access and HEOR teams, the challenge is not only finding information. The real challenge is knowing:

  • Which changes matter for your portfolio

  • Which countries require attention

  • Which developments signal an opportunity or risk

  • Which changes should trigger internal action

  • When to engage with payers, HTA bodies, clinical societies, or reimbursement stakeholders

What Access Intelligence Tracks

MTRC Access Intelligence monitors developments across the main pillars of market access:

Reimbursement and coding
  • New procedure codes
  • Changes in procedure nomenclatures
  • DRG system updates
  • New or revised reimbursement tariffs
  • Add-on reimbursement mechanisms
  • Outpatient reimbursement codes
  • Innovation payment schemes
Payer and decision-maker activity
  • National coverage decisions
  • National payer policies
  • National decision-maker assessments
  • Changes in funding rules
  • Consultations and stakeholder engagement opportunities
Health technology assessment
  • Newly initiated HTAs
  • Published HTA reports
  • Ongoing assessment activity
  • National and regional HTA decisions
  • Global HTA developments relevant to MedTech and IVDs
Market access environment
  • Structural changes in reimbursement or HTA systems
  • New access pathways
  • Changes in innovation funding programs
  • Updates from relevant governmental and public bodies
  • Clinical practice guidelines developed by governmental or public organizations

What Makes MTRC Access Intelligence Different

MedTech-specific focus

MTRC focuses on medical devices, IVDs, and digital health technologies. This allows the intelligence system to capture the reimbursement and HTA developments that matter specifically for medical technologies.

Pan-European MTRC market access expertise

Access Intelligence is supported by MTRC’s deep knowledge of European reimbursement and market access systems. This is especially important because coding, reimbursement, payer approval, and HTA systems differ substantially by country.

Manual expert review

Reports are identified, reviewed, classified, and summarized by MTRC analysts. The current service emphasizes that reports are developed using manual search and categorization, not automated search robots.

English-language summaries

Relevant developments are summarized in English, reducing the burden created by language barriers and fragmented national sources.

Portfolio relevance

Clients can configure the service around the countries, technology groups, and information types that matter to their business.

Optional advisory layer

For larger teams, Access Intelligence can go beyond monitoring and support interpretation, internal updates, and strategic decision-making.

Typical Use Cases

For Global and EMEA market access teams

Use Access Intelligence to maintain a structured view of reimbursement, HTA, payer, and access changes across countries and franchises.

Typical questions supported:

  • What access changes may affect our portfolio?
  • Are new HTA or reimbursement decisions emerging for our technology area?
  • Which countries show signals of future opportunity or risk?
  • What should we communicate internally to regional or global stakeholders?
For business-unit or franchise teams

Use Access Intelligence to follow developments in a specific technology area.

Typical questions supported:

  • What is changing in our therapeutic or procedural area?
  • Are competitors receiving HTA recommendations, coverage decisions, or reimbursement changes?
  • Are new codes, tariffs, or innovation funding routes emerging?
  • Should we adapt launch, evidence, or payer engagement plans?
For SMEs and start-ups

Use Access Intelligence as an affordable early-warning system while building European market access capability.

Typical questions supported:

  • Are there major developments in countries relevant to our launch?
  • Are new pathways opening for our technology type?
  • Are similar technologies being assessed or reimbursed?
  • Where should we focus limited market access resources?

Frequently Asked Questions

No. It is a structured market access intelligence system. Information is filtered, classified, summarized, and organized around MedTech-relevant countries, technologies, and access pathways.

Yes. The service can be customized by geography and technology group.

Yes. User access depends on the selected package and internal usage requirements.

Yes. Database access allows users to search historical developments, filter by tags, and retrieve relevant records. The current database format includes historical records from 2021 onwards.

Yes. Professional and Enterprise packages can include structured snapshots, and Enterprise can include strategic intelligence calls and an annual portfolio review.

The service is designed for MedTech, IVD, and digital health companies. MTRC does not position Access Intelligence as a product for consulting companies.